-transparent.png){kind=logo}
HS3, a highly phosphorylated dinucleoside originally purified from the fungus Achlya, has been isolated from Chinese hamster ovary cells undergoing glutamine starvation. The HS3 compounds obtained from the fungal and mammalian sources exhibited similar physical and chemical properties. This unusual dinucleotide may be an important regulator of eucaryotic ribonucleoside diphosphate reductase activity; for 50 micrometer HS3, isolated from either mammalian or fungal cells, significantly inhibited CDP reduction in Achlya or hamster cell preparations, but only marginally affected the activity of the enzyme from E. coli. Studies with HS3 isolated from Achlya and partially purified mammalian ribonucleotide reductase indicated that the compound noncompetitively inhibited the reduction of varying concentrations of the substrates CDP, ADP and GDP with Ki values of 23 micrometer, 14 micron and 16 micron respectively. These inhibitor concentrations are well below the estimated intracellular levels of HS3 in glutamine starved cells and suggest that HS3 inhibition of ribonucleotide reduction may be responsible for the rapid inhibition of DNA synthesis seen under these culture conditions.
W H Lewis, and
D R McNaughton, and
S H Goh, and
H B LéJohn, and
J A Wright
December 1992,
Biochemistry and cell biology = Biochimie et biologie cellulaire,
W H Lewis, and
D R McNaughton, and
S H Goh, and
H B LéJohn, and
J A Wright
January 1976,
Advances in enzyme regulation,
W H Lewis, and
D R McNaughton, and
S H Goh, and
H B LéJohn, and
J A Wright
April 1984,
The EMBO journal,
W H Lewis, and
D R McNaughton, and
S H Goh, and
H B LéJohn, and
J A Wright
January 1980,
Advances in enzyme regulation,
W H Lewis, and
D R McNaughton, and
S H Goh, and
H B LéJohn, and
J A Wright
January 1983,
Molecular and cellular biochemistry,
W H Lewis, and
D R McNaughton, and
S H Goh, and
H B LéJohn, and
J A Wright
May 1984,
Archives of biochemistry and biophysics,
W H Lewis, and
D R McNaughton, and
S H Goh, and
H B LéJohn, and
J A Wright
October 1984,
Cancer treatment reports,
W H Lewis, and
D R McNaughton, and
S H Goh, and
H B LéJohn, and
J A Wright
May 1973,
Cancer research,
W H Lewis, and
D R McNaughton, and
S H Goh, and
H B LéJohn, and
J A Wright
December 1993,
The Journal of biological chemistry,
W H Lewis, and
D R McNaughton, and
S H Goh, and
H B LéJohn, and
J A Wright
November 1991,
Cancer research,
